Macrogol Aurovitas

Macrogol 4000, the active ingredient in Macrogol Aurovitas, is an osmotic laxative presented as an oral powder for solution for oral use. It is employed to relieve constipation and to prepare the bowel for diagnostic procedures such as colonoscopy.

GNH USA supplies Macrogol Aurovitas as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product meets European Union quality standards, is manufactured under GMP conditions, and its consistent purity and performance support clinical use across diverse patient populations.

Macrogol Aurovitas (macrogol 4000) is an osmotic laxative used to manage conditions involving reduced bowel motility.

- Constipation: softens stool and facilitates regular bowel movements. - Chronic idiopathic constipation: provides long‑term relief of infrequent stools. - Bowel preparation for colonoscopy: clears intestinal contents before diagnostic procedures. - Fecal impaction: helps evacuate impacted stool in acute settings.

Macrogol Aurovitas may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Abdominal bloating: sensation of fullness or swelling in the abdomen. - Flatulence: increased intestinal gas. - Nausea: mild feeling of queasiness. - Abdominal discomfort: cramping or mild pain. - Diarrhea: loose stools occurring more frequently. - Increased thirst: sensation of needing more fluids.

Serious or Rare Side Effects: - Severe electrolyte imbalance: abnormal levels of sodium, potassium, or other electrolytes. - Allergic reaction: rash, itching, or angioedema. - Dehydration: excessive loss of body fluids. - Severe abdominal pain: intense or persistent pain. - Rectal bleeding: presence of blood in stool. - Anaphylaxis: rare life‑threatening allergic response.

When prescribing or dispensing Macrogol Aurovitas, consider the following safety measures. - Assess renal function: avoid use in patients with severe renal impairment. - Monitor electrolytes: especially during prolonged therapy. - Use with caution in the elderly: higher risk of dehydration. - Avoid in intestinal obstruction: may exacerbate blockage. - Review concomitant medications: potential for reduced absorption of other oral drugs. - Store at ambient temperature: keep below 25°C, protect from moisture and direct sunlight.

Macrogol 4000 can interact with other agents that affect gastrointestinal function or fluid balance.

Major Interactions (Avoid): - Other osmotic laxatives (e.g., lactulose): risk of severe diarrhea. - Mineral oil: may reduce laxative efficacy. - Diuretics: increased risk of electrolyte disturbances.

Moderate Interactions (Monitor Closely): - Antacids: may alter absorption of certain oral medications. - Oral antibiotics: potential changes in gut flora; monitor therapeutic response. - NSAIDs: increased likelihood of gastrointestinal irritation. - Oral supplements (e.g., iron): may have reduced absorption due to altered transit time.